Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation - Treatment with anti-D immunoglobulin

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 173-174

  Lee, S J ^a   Churchill, W Hallowell ^a,b   Konugres, A ^b   Gilliland, D G ^a   Antin, J H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti D immunoglobulin; Bone marrow transplantation; Chronic graft versus host disease; Idiopathic thrombocytopenic purpura

Indexed keywords

IMMUNOGLOBULIN; PREDNISONE; RHESUS D ANTIBODY; TACROLIMUS;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; GRAFT VERSUS HOST REACTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 1842336875     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700634     Document Type: Article

References (10)

1. Anasetti C, Rybka W, Sullivan KM et al. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054-1058.
2. Sullivan KM, Witherspoon RP, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72: 546-554.
3. Spruce W, Forman S, McMillan R et al. Idiopathic thrombocytopenic purpura following bone marrow transplantation. Acta Haematol 1983; 69: 47-51.
4. Minchinton RM, Kendra J, Waters AH, Barrett AJ. Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 1982; 2: 627-629.
5. Rodeghiero F, Schiavotto C, Castaman G et al. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematologica 1992; 77: 248-252.
6. Andrew M, Blanchette VS, Adams M et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992; 120: 522-527.
7. Bussel JB, Graziano JN, Kimberly RP et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of action. Blood 1991; 9: 1884-1893.
8. Salama A, Mueller-Eckhardt C. Use of Rh antibodies in the treatment of autoimmune thrombocytopenia. Transf Med Rev 1992; 6: 17-25.
9. Ambriz P, Munoz R, Quintanar E et al. Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. Radiology 1985; 155: 793-796.
10. Verheyden CN, Beart RW, Clifton MD, Phyliky RL. Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc 1978; 53: 442-446.